Psychemedics (PMD)
(Delayed Data from NSDQ)
$2.05 USD
-0.12 (-5.47%)
Updated Jul 26, 2024 03:20 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PMD 2.05 -0.12(-5.47%)
Will PMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PMD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PMD
Bullish Friday For Marijuana Stocks - GreenGro Technologies, Leafbuyer Techs Among Top Gainers
Marijuana Stock Movers For July 25, 2024
Cannabis Stock Gainers And Losers From July 24, 2024
Bearish Friday For Marijuana Stocks - Global Compliance, 1933 Industries Among Top Gainers
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing